Table 5.
Relationships between expression of KIF23 and clinical pathological parameters of 115 OV patients
| Items | n | Low | High | High positive rate (%) | P-value | ||
|---|---|---|---|---|---|---|---|
|
|
|
||||||
| (-) | (+) | (++) | (+++) | ||||
| FIGO stage | < 0.05 | ||||||
| I-II | 47 | 4 | 7 | 17 | 19 | 76.6 | |
| III-IV | 68 | 2 | 1 | 20 | 45 | 95.59 | |
| Differentiation | < 0.05 | ||||||
| Well-Moderate | 54 | 5 | 5 | 18 | 25 | 79.63 | |
| Poorly | 61 | 1 | 3 | 19 | 39 | 95.08 | |
| Lymph node metastasis | < 0.05 | ||||||
| Yes | 28 | 0 | 0 | 10 | 18 | 100 .00 | |
| No | 87 | 6 | 8 | 27 | 46 | 83.91 | |
| Pathological subtype | > 0.05 | ||||||
| Serous | 79 | 2 | 4 | 27 | 46 | 92.41 | |
| Mucinous | 9 | 0 | 1 | 3 | 5 | 88.89 | |
| Endometrioid | 18 | 2 | 2 | 4 | 10 | 77.78 | |
| Clear cell carcinoma | 9 | 2 | 1 | 3 | 3 | 66.67 | |